TubeMogul Inc.

(TUBE) Trade

By |

Profile

Orphazyme A/S is a Danish biotech company. It is engaged in the development of paradigm-changing medicines for the treatment of protein misfolding diseases. The company's lead candidate, arimoclomol, is in development for four severe orphan diseases; two neuromuscular diseases, sporadic Inclusion Body Myositis and Amyotrophic Lateral Sclerosis, and two lysosomal storage diseases, Niemann-Pick disease Type C and Gaucher disease.

Contact Information

Website: www.orphazyme.com
Email: investor@tubemogul.com
Main Phone: +45 39178272
Address: Ole Maaloes Vej 3
Address 2: Suite 2
State: CA
City / Town: Copenhagen
Country: DK
Postal Code: DK-2200

Issuer Information

Exchange: NGS
Employees: 114
NAICS: Software Publishers(511210)

Equities News

Profile

Orphazyme A/S is a Danish biotech company. It is engaged in the development of paradigm-changing medicines for the treatment of protein misfolding diseases. The company's lead candidate, arimoclomol, is in development for four severe orphan diseases; two neuromuscular diseases, sporadic Inclusion Body Myositis and Amyotrophic Lateral Sclerosis, and two lysosomal storage diseases, Niemann-Pick disease Type C and Gaucher disease.

Contact Information

Website: www.orphazyme.com
Email: investor@tubemogul.com
Main Phone: +45 39178272
Address: Ole Maaloes Vej 3
Address 2: Suite 2
State: CA
City / Town: Copenhagen
Country: DK
Postal Code: DK-2200

Issuer Information

Exchange: NGS
Employees: 114
NAICS: Software Publishers(511210)

Equities News

$ 14.00 $ 0. (0.00%)
Last Price 14.00 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close 14.00
Last Trade Volume 0 52 Wk Hi 14.46 52 Wk Low 7.00
Market Cap 379.1 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 27,079,630.00 EPS (TTM) -1.77 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 0
Number of Buys 0 0
Number of Sells 0 0
Net Activity 0 0
Last 10 Buys Shares
Brett Wilson 1,000
Chip Scovic 1,000
John Hughes 1,000
Brett Wilson 1,000
Jack R. Lazar 1,000
Brett Wilson 1,000
Last 10 Sell Shares
Keith Eadie 1,000
Brett Wilson 1,000
Brett Wilson 1,000
William B. Elmore 1,000
William B. Elmore 1,000
William B. Elmore 1,000
William B. Elmore 1,000
William B. Elmore 1,000
William B. Elmore 1,000
William B. Elmore 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 17 17 17 17
Low Target Price Estimate 11 11 11 11
Mean Target Price Estimate 14.29 14.29 14.29 14.29
Standard Deviation 1.89 1.89 1.89 1.89
Date of Most Recent Estimate 11/17/16 11/17/16 11/17/16 11/17/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 6 4
Moderate Buy 0 0 0 0
Hold 8 9 4 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.45 2.5 1.8 2